Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care.
Glucocorticoid medications given in primary care settings are associated with suicidal behaviors and severe neuropsychiatric disorders, new research suggests. PubMed. Psychiatry, 02/17/12. (Also see: Steroids)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care.
Started by
Joelf
, Apr 24 2012 12:25 AM
No replies to this topic
#1
Joelf
-
- ISN Administrators
-
- 2,765 posts
Platinum Plus Member
- Location:West Sussex
Posted 24 April 2012 - 12:25 AM
Jo Frowde
ISN Sclero Forums Manager
ISN News Guide for Scleroderma Medical News
ISN Chat Host
International Scleroderma Network (ISN)
ISN Sclero Forums Manager
ISN News Guide for Scleroderma Medical News
ISN Chat Host
International Scleroderma Network (ISN)
